Electromed ELMD
NYSE ELMD
$39.90 -0.82 (-2.01%)
At close: Aug 20, 2026 · 1:09 PM UTC

Electromed (ELMD) Change in Account Payables (2021 - 2023)

Electromed (ELMD) posted quarterly Change in Account Payables of -$349000.0 for Q1 2023, down 353.25% year-over-year from $137810.3 in Q1 2022, and down 237.4% quarter-over-quarter from $254000.0 in Q4 2022.

Electromed (ELMD) Change in Account Payables (2021 - 2023) Analysis & Trends

Electromed (ELMD) has reported Change in Account Payables for 3 consecutive years, with -$349000.0 the latest figure, recorded in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Abbott Laboratories 198.95 Bn 193.35 Bn 7.27 Bn -
2 Stryker 128.10 Bn 124.63 Bn 4.50 Bn 71.00 Mn
3 Medtronic 118.91 Bn 109.69 Bn 6.41 Bn -
4 Boston Scientific 73.43 Bn 72.89 Bn 3.85 Bn -
5 Edwards Lifesciences 51.91 Bn 47.66 Bn 1.35 Bn -
6 Dexcom 34.52 Bn 32.58 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.94 Bn 31.83 Bn 2.18 Bn -200.00 Mn
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn -
9 Steris 23.14 Bn 22.66 Bn 684.20 Mn 4.30 Mn
10 Electromed 327.63 Mn 310.64 Mn 14.64 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2023 -349,000.00
Mar 31, 2023 -349,000.00
Dec 31, 2022 254,000.00
Dec 31, 2022 254,000.00
Sep 30, 2022 -175,000.00
Sep 30, 2022 -175,000.00
Mar 31, 2022 -77,000.00
Mar 31, 2022 -77,000.00
Dec 31, 2021 132,000.00
Dec 31, 2021 132,000.00
Sep 30, 2021 -498,000.00
Sep 30, 2021 -498,000.00